The ear, skin, and purified serosal mast calls of WBB6F1/J-+/+ (WB-+/+) and WCB6Ft/J-+/+ (WC-+/+) mice contain high steady-state levels of the transcripts that encode mouse mast cell protease (mMCP) 2, mMCP-4, mMCP-5, mMCP-6, and mouse mast cell carboxypeptidase A (mMC-CPA). In contrast, no mast cell protease transcripts are present in abundance in the ear and skin of and WCB6F1/J-SI/S1 d (SI/SI a) mice which are mast cell-deficient in vivo due to defects in their c-kit and c-kit ligand genes, respectively. We now report that the immature bone marrow-derived mast cells (mBMMC) obtained in vitro with recombinant interleukin 3 (rIL-3) or WEHI-3 cell conditioned medium from WB-+/+, WC-+/+, W/W ~, and SI/SI d mice all contain high steady-state levels of the mMCP-2, mMCP-4, mMCP-5, mMCP-6, and mMC-CPA transcripts. As assessed immunohistochemically, mMCP-2 protein and mMCP-5 protein are also present in the granules of mBMMC from WB-+/+, WC-+/+, and W/W ~ mice. That SI/SI d and W/W ~ mBMMC contain high steady-state levels of five granule protease transcripts expressed by the mature serosal, ear, and skin mast cells of their normal +/+ littermates suggests that c-kit-mediated signal transduction is not essential for inducing transcription of these protease genes. Because rlL-4 inhibits the rlL-10-induced expression of mMCP-1 and mMCP-2 in BALB/cJ mBMMC, the ability of rlL-4 to influence protease mRNA levels in WC-+/+ mBMMC and W/W ~ mBMMC was investigated. Although rlL-10 induced expression of the mMCP-1 transcript in WC-+/+ and W/W ~ mBMMC, rIL-4 was not able to suppress the steady-state levels of the mMCP-1 transcript or any other protease transcript in these cuhured mast cells. Thus, not only do BALB/cJ mBMMC express fewer granule proteases than mBMMC from mast cell-deficient strains and their normal littermates but the subsequent induction of late-expressed proteases in BALB/cJ mBMMC is more tightly regulated by IL-3 and IL-4.
W
'hen bone marrow cells from the BALB/cJ mouse are cultured in the presence of recombinant (r)IL-3 or conditioned medium containing IL-3, immature mouse bone marrow-derived mast cells (mBMMC) 1 are obtained (1, 2) l~hat have high steady-state levels of the transcripts that en- code mouse mast cell protease (mMCP) 5 (3), mMCP-6 (4), and mouse mast cell carboxypeptidase A (mMC-CPA) (5) . BALB/cJ mBMMC exposed to recombinant c-kit ligand (rKL), a fibroblast-derived cytokine (6) , have high steady-state levels of the mMCP-4 transcript in addition to the other protease transcripts (7) . BALB/cJ mBMMC exposed concomitantly to rKL and either rlL-9 or rlL-10 contain high steady-state levels of the mMCP-1 and mMCP-2 transcripts in addition to the mMCP-4 transcript (8) . However, the ability of rKL, rlL-9, or rlL-10 to induce BALB/cJ mBMMC to accumulate high steady-state levels of the mMCP-1, mMCP-2, and mMCP-4 transcripts is inhibited when these cells are exposed concomitantly to either rlL-3 or rlL-4 (7) (8) (9) (10) (11) .
The WCBF~/J-SI/SI a (SI/SI d) and WBB6Ft/J-W/W v (W/W v) mouse strains possess abnormalities in the membrane-spanning domain of KL (6, 12) and the tyrosine kinase domain of c-kit (the membrane receptor for KL) (13) , respectively. Both strains normally have very few mast cells in their tissues (14) (15) (16) , and the levels of all mMCP transcripts in their ears and skin are below detection (17) even though large numbers of mBMMC can be generated by culturing the hematopoietic progenitor cells of these mice in the presence ofrlL-3 or IL-3-enriched conditioned medium (18) . Connective tissue-type mast cells (CTMC) can be elicited in the skin of the W/W v mouse but not in the SI/SI d mouse at sites of idiopathic chronic dermatitis (19) or by repeated application of phorbol ester (20) . Because W/W ~ mice reconstituted with mBMMC derived from the WBB6F1/J-+/+ (WB-+/+) mouse can produce cells at different anatomical sites that histochemically resemble either CTMC, serosal mast cells (SMC), or mucosal mast cells (21) , it was concluded that in the BALB/cJ mouse mMCP-5 (3, 22) , mMCP-6 (4), and mMC-CPA (5) are early-expressed proteases and that mMCP-1 (23, 24) , mMCP-2 (25), and mMCP-4 (26) are late-expressed proteases. In addition, because rKL-developed mBMMC histochemically resemble SMC and CTMC, preferentially synthesize heparin proteoglycans, and contain high steady-state levels of the mMCP-4 transcript (7, 27) , it was concluded that KL and its receptor preferentially induce mast cell-committed progenitor cells to differentiate in a SMC and/or CTMC lineage.
In the present study, mBMMC were developed with rlL-3 or with IL-3-enriched WEHI-3 cell conditioned medium (WCM) in the absence of KL from mast cell-deficient strains, their +/+ littermates, BALB/cJ mice, and C57BL/6J mice. We now report that KL and its receptor are not essential for inducing expression of those granule proteases that are specifically found in SMC and CTMC.
Materials and Methods
Cell Culture. mBMMC were obtained by separately culturing bone marrow cells from the femurs and tibias of BALB/cJ, WB-+/+, WCB6F1/J-+/+ (WC-+/+), W/W ~, SI/SI a, and C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) for 2-5 wk in enriched medium (RPMI 1640 containing 0.1 mM nonessential amino acids, 2 mM 1.-glutamine, 10% FCS [GIBCO BRL, Gaithersburg, MD], 100 U/ml penicillin, 100 gg/ml streptomycin, 10 t~g/rrd gentamicin, and 50 gM 2-mercaptoethand) supplemented with either 100 U/m1 mouse rlL-3 (Genzyme Corp., Boston, MA) or 50% WEHI-3 cell (line TIB-68; American Type Culture Collection, gockville, MD) CM (1, 2). As assessed by PCR analysis, WEHI-3 cells do not express KL (Cheng, H.J., andJ. G. Flanagan, unpublished observation). Every 7 d, the nonadherent cells in the cultures were transferred into new flasks containing fresh culture medium. In some experiments, 3-wk-old mBMMC from BALB/cJ, WB-+/+, or WC-+/+ mice were separately cultured for 72 h in 50% WCM/50% enriched medium supplemented with 100 U/ml mouse rIL-10 alone or with both 50 U/ml mouse rIL-4 (Genzyme Corp.) and mouse rIL-10 (8-11). The concentration sdected for each cytokine was identical to or higher than that which was previously shown to elicit fully a particular biologic response in mouse mast cells.
Histackemical, Immunokistockemical, Histamine, and mRNA Analyses of mBMMC. Cytocentrifuge preparations of mBMMC exposed to various combinations of cytokines were stained with toluidine blue or with alcian blue followed by saffanin (28) . More than 100 cells were assessed histochemically in each experiment. For immunohistochemical analysis, mBMMC in Carnoy's fixative were washed with PBS containing 0.2% Tween-20 and 0.1% BSA (PTB buffer), incubated for 30 min at 37~ in PBS containing 0.05% Tween-20 and 4% goat serum, and then incubated for 2 h at 21~ with a~nity-purified anti-mMCP-2(56~n) IgG (11) or antimMCP-5046q6z) IgG (29) diluted in goat serum. The cells were washed in PTB buffer, incubated for 1 h at room temperature in PTB buffer supplemented with biotinylated goat anti-rabbit IgG, washed again, incubated in the alkaline phosphatase Vectastain ABC reagent (Vector Laboratories Inc., Burlingame, CA) for 30 rain at room temperature, and then washed again in PTB buffer. In each protocol, control cell preparations were processed without primary antibodies.
For histamine analyses, cells were suspended in HBSS at a density of m5 x 106 cells/ml and then were sonicated at 4~ with a Branson Sonifier (15 pulses/50% pulse cycle; Branson Ultrasonics Corp., Danbury, CT). The resulting cell lysates were diluted 1/1,000 in HBSS, and their histamine contents were determined with a radioimmunoassay kit (Amac Inc., Westbrook, ME) (30) .
For quantitation of steady-state protease mRNA levels in mBMMC, approximately equal amounts of total cellular RNA (isolated by the method of Chomczynski and Sacchi [31] ) were applied to individual lanes of 1.3% agarose-formaldehyde gels, and the gels were subjected to electrophoresis for 16-22 h. The separated RNA was transferred to nylon membranes (MagnaGraph; Micron Separations Inc., Westboro, MA) (32) . The resulting blots were analyzed with [32p]dCTP (,,o3,000 Ci/mmol; DuPont/New England Nuclear, Boston, MA) random prime-labeled (Stratagene, La Jolla, CA) mMCP-1 (9, 24), mMCP-2 (25), mMCP-4 (9, 26), mMCP-5 (3), mMCPo6 (4), mMC-CPA (5), serglycin proteoglycan peptide core (33) , and 3-actin (34) cDNA probes. Hybridizations were performed at 68~ for 1--4 h with QuikHyb (Stratagene). The RNA blots were washed at 55-60~ in 30 mM NaC1, 3 mM sodium citrate, 0.1% SDS, and autoradiography was performed with Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY). Usually, the same blot was assessed for the presence of other transcripts after the previous radiolabeled probe was removed by incubation of the blot for 1 h at 75~ in 0.25 mM EDTA, 0.1x Denhardt's solution, 5 mM Tris-HC1, and 0.05% pyrophosphate. In some cases, relative levels of individual transcripts were quantitated by directly measuring the amount of blot-bound radioactivity with a 32p imaging system (Betascope 603; IntelliGenetics, Inc./Betagen, Mountain View, CA). The data were then B-actin corrected for variable total RNA loading in the lanes of the gel.
The mMCP-4 probe used in the above RNA blot analyses crossreacts weakly (9) with a gene that encodes a mast cell-like serine protease that has been designated mMCP-L (26). Thus, a RNase protection analysis was performed to confirm the presence of the mMCP-2 and mMCP-4 transcripts in WB-+/+ mBMMC. Antisense cRNA probes corresponding to residues 804-956 of a mMCP-2 cDNA and residues 497-633 ofa mMCP-4 cDNA were generated from their plasmids with T3 or T7 primers and a kit from Ambion Inc. (Austin, TX). Each clLNA probe was labeled with [32p]dUTP (m800 Ci/mmol; DuPont/New England Nuclear) and was then separately incubated overnight at 43~ with ,'~5 #g of total RNA isolated from BALB/cJ mBMMC and WB-+/+ mBMMC. The sizes of the protected fragments were analyzed on 6% polyacrylamide/8 M urea gels.
Results
Protease mRNA Levels in mBMMC Generated from Different Strains. 4-wk-old IL-3-dependent mBMMC from BALB/cJ mice contained high steady-state levels of the mMCP-5, mMCP-6, and mMC-CPA transcripts but undetectable levels of the mMCP-1, mMCP-2, and mMCP-4 transcripts (Fig.  1) . mBMMC generated from W / W ~ mice, SI/S1 a mice, and their +/+ littermates contained not only high steady-state levels of the mMCP-5, mMCP-6, and mMC-CPA transcripts but also high steady-state levels of the mMCP-2 and mMCP-4 transcripts. The presence of the mMCP-2 and mMCP-4 transcripts in WB-+/+ mBMMC was confirmed by KNase protection assays. Total R N A from these mBMMC protected a radiolabeled 136-bp fragment of the mMCP-4 probe and a 152-bp fragment of the mMCP-2 probe from degradation (data not shown). C57BL/6J mBMMC contained high steadystate levels of the mMCP-5, mMCP-6, and mMC-CPA transcripts but not the mMCP-1, mMCP-2, or mMCP-4 transcripts (data not shown).
mBMMC from WB-+/+ mice and BALB/cJ mice were assessed for their histochemistry and time course of appearance of the steady-state levels of the mMCP-2, mMCP-4, mMC-CPA, and serglycin transcripts. No cells in the starting bone marrow from either strain stained with toluidine blue; only a few stained with toluidine blue at day 3. However at day 10, 40-60% of the cells in the cultures from both strains contained metachromatic granules when stained with toluidine blue. The serglycin transcript was detected in the starting bone marrow cells from both strains (Fig. 2) , but the steadystate level of this transcript was notably higher at day 3 and the level of this proteoglycan peptide core transcript remained very high throughout the subsequent 28 d of culture. A substantial increase in the steady-state level of the mMC-CPA transcript also occurred at day 3. No mMCP-2 or mMCP-4 transcripts were detected in the BALB/cJ mBMMC cultures at days 0, 3, 7, 10, 14, 21, and 28. In contrast, W B -+ / + mBMMC contained detectable steady-state levels of the mMCP-2 transcript at day 3, moderate levels at day 7, and maximal levels at days 10-14. The mMCP-4 transcript was detected in cultures of W B -+ / + mBMMC at day 7, but maximal levels of this protease transcript were not detected until day 14.
Histochemistry, Immunohistochemistry, and Histamine Content of mBMMC from Different Strains. Whether grown in the presence of rlL-3 or WCM, mBMMC from BALB/cJ, WB-+/+, W C -+ / + , SI/SI a, W / W ~, and C57BL/6J mice were alcian blue +/safranin-when stained, suggesting that the mBMMC from these strains exhibit no substantial difference in the amount of heparin they synthesize. Whether derived with rlL-3 or WCM, mBMMC from BALB/cJ, WB-+/+, W C -+ / + , SI/SI a, or W/W" mice all contained <300 ng histamine/106 cells. The mean percentages of mBMMC (>325 cells examined in each strain) that reacted with antimMCP-5046-t62 ) IgG were 63% for WC-+/+ (Fig. 3) , 23% for W B -+ / + (data not shown), 65% for W/W" (Fig. 3) , and 54% for BALB/cJ (Fig. 3) mice. Whereas 53, 48, and 72% of the mBMMC from the WC-+/+, WB-+/+, and W / W ~ strains, respectively, reacted with anti-mMCP-21s6-7t) IgG, only 1% of the mBMMC from the BALB/cJ and C57BL/6J mouse strains reacted with mMCP-2. Approximately 1% of the mBMMC in all preparations were reactive when incubated without primary anti-mMCP-2/56-Tt) IgG, or without primary anti-mMCP-5046-t62 ) IgG.
Effects of Stimulatory and Inhibitory Cytokines on the SteadyState mMCP m R N A Levels in mBMMC from WB-+/+, W / W ~, and BALB/cJ
Mice. Since it had been previously shown that rlL-10 induces and rlL-4 suppresses the expression of mMCP-1 and mMCP-2 in BALB/cJ mBMMC, mBMMC from W B -+ / + and W / W ~ mice were exposed to WCM and rlL-10 in the presence or absence of rlL-4 to assess the ability of these two recombinant cytokines to alter protease expression. After exposure to rlL-10 for 72 h, both BALB/cJ mBMMC and WB-+/+ mBMMC contained high steady-state levels of the mMCP-1 and mMCP-2 transcripts (Fig. 4, lanes 2 and 5) . In the depicted experiment, the levels of the mMCP-1, and mMCP-2 transcripts in BALB/cJ mBMMC exposed concomitantly to WCM, rlL-10, and rlL-4 (lane 3) were 55 and 64% less, respectively, than the levels in BALB/cJ mBMMC exposed to WCM and rlL-10 (lane 2). In contrast, the level of the mMCP-1 and mMCP-2 transcripts in W B -+ / + mBMMC exposed concomitantly to WCM, rlL-10, and rlL-4 (lane 6) were only 3 and 9% less, respectively, than the levels in WB-+ / + mBMMC exposed to WCM and rlL-10 (lane 5). In a second experiment, the level of mMCP-1 mtLNA in BALB/cJ mBMMC was 51% less when the cells were exposed concomitantly to WCM, rlL-10, and rlL-4 than when they were exposed to WCM and rlL-10; there was no decrease in the level of this protease transcript in WB-+ / + mBMMC exposed concomitantly to WCM, rlL-10, and rIL-4. Similar findings were obtained in a third experiment with W / W v mBMMC (data not shown). Thus, as it did in BALB/cJ mBMMC, rIL-10 induced high steady-state levels of the mMCP-1 transcript in W / W ~ and WB-+ / + mBMMC. However, unlike its effect on BALB/cJ mBMMC, rIL-4 was not able to suppress the level of the induced mMCP-1 and constitutive mMCP-2 transcripts in mBMMC obtained from the W / W ~ and WB-+ / + strains.
To assess further the ability of rIL-4 to regulate protease levels in WB-+/+ mBMMC, these cells were cultured for an additional 2 wk in the presence of rlL-3 alone or in the presence of both rlL-3 and rIL-4. In two separate experiments, Figure 4 . RNA blot analyses of the effect of rlh.4 on the rlL-10-induced expression of mMCP-1 and mMCP-2 in mBMMC. BALB/cJ mBMMC (lanes I-3) and WB-+/+ mBMMC (lanes 4--6) were cultured for an additional 72 h in WCM alone (lanes 1 and 4) , WCM supplemented with rIL-10 (lanes 2 and 5), or WCM supplemented with rib10 and rlL-4 (lanes 3 and 6). W / W ~ BMMC (not shown) react in the same manner as WB-+/+ mBMMC. rlL-4 did not reduce the constitutive high steady-state levels of the mMCP-2 or mMCP-4 transcripts in the cells of this strain (data not shown).
Discussion
BALB/cJ mouse SMC express mMCP-4 but not mMCP-1, whereas BALB/cJ mouse mucosal mast cells express mMCP-1 but not mMCP-4 (9, (22) (23) (24) . We previously reported that rlL-10-treated BALB/c mBMMC express high steady-state levels of the mMCP-1 transcript but not the mMCP-4 transcript (9), whereas KL-treated mBMMC express the same pand of proteases as SMC, induding mMCP-4 (7). Because W/W ~ and Sl/Sl a mice do not contain appreciable numbers of SMC (15), it was concluded that c-kit receptor and its ligand induce mast ceU-committed progenitor calls to differentiate in a SMC lineage. We report in this study that mBMMC developed from W/W ~ mice, SI/SI d mice, and their +/+ littermates differ from mBMMC developed from C57BL/6J mice and BALB/cJ mice in that they additionally have high steady-state levels of mMCP-2 and mMCP-4 transcripts ( Fig.  1 ) and mMCP-2 protein (Fig. 3) . High steady-state levels of the mMC-CPA and scrglydn transcripts were obtained 3 d after bone marrow cells from WB-+/+ and BALB/cJ mice were exposed to WCM. WB-+/+ mBMMC contained measurable levels of the mMCP-2 and mMCP-4 transcripts at day 7 and maximal levels at day 14. However, even at day 28, the steady-state levels of the mMCP-2 and mMCP-4 transcripts were below detection in BALB/cJ mBMMC (Fig. 2) . The observation that W/W ~ and Sl/Sl d mBMMC express every protease that is found in the SMC of their normal +/+ littermates ( Fig. 1 ) now indicates that c-kit-mediated signal transduction is not essential for inducing transcription of SMC-specific protease genes.
It was previously shown that rKL dicits the expression of mMCP-4 in BALB/cJ mBMMC (7), whereas rlL-9 or rIL-10 in the presence ofrKL dicit the expression of mMCP-1 and mMCP-2 in these cells (8) . When present concomitantly, rIL-3 and rlL-4 each suppress the rIL-9-induced accumulation of the mMCP-1 and mMCP-2 transcripts and the rKLinduced accumulation of the mMCP-4 transcript in BALB/cJ mBMMC (7, 8) . Although mBMMC from the WB-+/+ and WC-+/+ strains constitutively express mMCP-2 and all of the other granule proteases of SMC, they still require rlL-10 to induce the mucosal mast call-specific protease (23) mMCP-1 (Fig. 4) . rlL-4 was not able to suppress the rlL-10-induced expression of the mMCP-1 transcript in WC-+/+ mBMMC and W/W ~ mBMMC or any other protease transcript in these mast cells (Fig. 4) . The resistance of the mBMMC from the W/W ~, SI/SI d, and +/+ strains to the suppressive effects of rlL-3 and rlL-4 could be explained by a difference in the mast call-committed progenitor ceUs in their bone marrows. During the first week of culture of bone marrow cells in the presence of rIL-3 or WCM, mast cells are a small proportion of the total cells in the culture (1, 2, 18) . Thus, an alternative explanation for the expression of mMCP-2 and mMCP-4 in WB-+/+ mBMMC and WC-+/+ mBMMC is that the contaminating cell types present during the first week of culture of the ceUs from these strains, but not from the BALB/cJ strain, release factors that are able to counteract the suppressive effects of IL-3 and IL-4 on the expression of certain proteases. If so, it is unlikely that these autocrine factors include IL-9 or IL-10, inasmuch as mBMMC from the +/+ strains do not express mMCP-1 (Fig. 1) unless they are exogenously stimulated (Fig. 4) .
The SI/SI a mouse and the W/W v mouse both have substantially diminished numbers of mast cells in their tissues. The SI/S1 a mouse does not produce the membrane-bound form of KL (6, 12) and the W/W ~ mouse possesses an altered c-kit (13) . The daily administration of 30 ~g/kg of rat rKL to WC-+/+ mice and SI/SI a mice produces a dramatic increase in the number of dermal mast cells (35) . Thus, whether acting directly or indirectly, KL is an important regulatory cytokine for this mast cell subclass in vivo. That bone marrow cells from both mast cell--deficient mouse strains give rise to large numbers of mBMMC in vitro (18) indicates that these mice do not have reduced numbers of mast cell--committed progenitor cells. Furthermore, mBMMC from both SI/SI a mice and W/W v mice are indistinguishable from mBMMC of their +/+ littermates in terms of their expression of high steady-state levels of the mMCP-2, mMCP-4, mMCP-5, mMCP-6, and mMC-CPA transcripts (Fig. 1) . Thus, mBMMC obtained from SI/SI a and W/W ~ mice with WCM or with rIL-3 alone express the five granule proteases found in the SMC and CTMC of their +/+ littermates. Gordon and Galli (20) reported that substantial numbers of mast cells can be elicited in the phorbol ester-treated skin of the W/W ~ mouse but not the skin of the SI/SI d mouse. In addition, Ody et al. (36) reported that normal numbers of mature safranin + mast cells appear in the skin of the W/W ~ mouse when high concentrations of rIL-3 are perfused into the peritoneum continuously for 28 d. That W/W ~ mBMMC contain high steady-state levels of five granule protease transcripts expressed by mature SMC and CTMC of their normal +/+ littermates suggests that in this strain, IL-3 can compensate for the signal transduction abnormality in c-kit to promote the viability and differentiation of progenitor ceUs into mast cells that exhibit the granule protease phenotype of SMC and CTMC. Nevertheless, the failure to elicit mast cells in inflammatory sites in the skin of the SI/Sl a mouse suggests that c-kit and its ligand are essential for the homing, retention, and/or life span of mast cell--committed progenitors in the skin. 
